Potent TRIM21 and complement-dependent intracellular antiviral immunity requires the IgG3 hinge.
Saved in:
| Title: | Potent TRIM21 and complement-dependent intracellular antiviral immunity requires the IgG3 hinge. |
|---|---|
| Authors: | Foss S; Centre for Immune Regulation (CIR) and Department of Biosciences, University of Oslo, N-0371 Oslo, Norway.; CIR and Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, P.O. Box 4956, N-0424 Oslo, Norway.; Institute of Clinical Medicine and Department of Pharmacology, University of Oslo and Oslo University Hospital, N-0372 Oslo, Norway., Jonsson A; Centre for Immune Regulation (CIR) and Department of Biosciences, University of Oslo, N-0371 Oslo, Norway.; CIR and Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, P.O. Box 4956, N-0424 Oslo, Norway.; Institute of Clinical Medicine and Department of Pharmacology, University of Oslo and Oslo University Hospital, N-0372 Oslo, Norway., Bottermann M; Protein and Nucleic Acid Chemistry Division, Medical Research Council Laboratory of Molecular Biology, Cambridge CB2-0QH, UK., Watkinson R; Protein and Nucleic Acid Chemistry Division, Medical Research Council Laboratory of Molecular Biology, Cambridge CB2-0QH, UK., Lode HE; Centre for Immune Regulation (CIR) and Department of Biosciences, University of Oslo, N-0371 Oslo, Norway.; CIR and Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, P.O. Box 4956, N-0424 Oslo, Norway.; Institute of Clinical Medicine and Department of Pharmacology, University of Oslo and Oslo University Hospital, N-0372 Oslo, Norway., McAdam MB; Centre for Immune Regulation (CIR) and Department of Biosciences, University of Oslo, N-0371 Oslo, Norway.; CIR and Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, P.O. Box 4956, N-0424 Oslo, Norway., Michaelsen TE; Department of Chemical Pharmacy, School of Pharmacy, University of Oslo, N-0371 Oslo, Norway.; Infection Immunology, Norwegian Institute of Public Health, N-0213 Oslo, Norway., Sandlie I; Centre for Immune Regulation (CIR) and Department of Biosciences, University of Oslo, N-0371 Oslo, Norway.; CIR and Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, P.O. Box 4956, N-0424 Oslo, Norway.; Institute of Clinical Medicine and Department of Pharmacology, University of Oslo and Oslo University Hospital, N-0372 Oslo, Norway., James LC; Protein and Nucleic Acid Chemistry Division, Medical Research Council Laboratory of Molecular Biology, Cambridge CB2-0QH, UK., Andersen JT; CIR and Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, P.O. Box 4956, N-0424 Oslo, Norway.; Institute of Clinical Medicine and Department of Pharmacology, University of Oslo and Oslo University Hospital, N-0372 Oslo, Norway. |
| Source: | Science immunology [Sci Immunol] 2022 Apr 29; Vol. 7 (70), pp. eabj1640. Date of Electronic Publication: 2022 Apr 29. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101688624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2470-9468 (Electronic) Linking ISSN: 24709468 NLM ISO Abbreviation: Sci Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35486676 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Potent TRIM21 and complement-dependent intracellular antiviral immunity requires the IgG3 hinge. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Foss+S%22">Foss S</searchLink>; Centre for Immune Regulation (CIR) and Department of Biosciences, University of Oslo, N-0371 Oslo, Norway.; CIR and Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, P.O. Box 4956, N-0424 Oslo, Norway.; Institute of Clinical Medicine and Department of Pharmacology, University of Oslo and Oslo University Hospital, N-0372 Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Jonsson+A%22">Jonsson A</searchLink>; Centre for Immune Regulation (CIR) and Department of Biosciences, University of Oslo, N-0371 Oslo, Norway.; CIR and Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, P.O. Box 4956, N-0424 Oslo, Norway.; Institute of Clinical Medicine and Department of Pharmacology, University of Oslo and Oslo University Hospital, N-0372 Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Bottermann+M%22">Bottermann M</searchLink>; Protein and Nucleic Acid Chemistry Division, Medical Research Council Laboratory of Molecular Biology, Cambridge CB2-0QH, UK.<br /><searchLink fieldCode="AU" term="%22Watkinson+R%22">Watkinson R</searchLink>; Protein and Nucleic Acid Chemistry Division, Medical Research Council Laboratory of Molecular Biology, Cambridge CB2-0QH, UK.<br /><searchLink fieldCode="AU" term="%22Lode+HE%22">Lode HE</searchLink>; Centre for Immune Regulation (CIR) and Department of Biosciences, University of Oslo, N-0371 Oslo, Norway.; CIR and Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, P.O. Box 4956, N-0424 Oslo, Norway.; Institute of Clinical Medicine and Department of Pharmacology, University of Oslo and Oslo University Hospital, N-0372 Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22McAdam+MB%22">McAdam MB</searchLink>; Centre for Immune Regulation (CIR) and Department of Biosciences, University of Oslo, N-0371 Oslo, Norway.; CIR and Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, P.O. Box 4956, N-0424 Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Michaelsen+TE%22">Michaelsen TE</searchLink>; Department of Chemical Pharmacy, School of Pharmacy, University of Oslo, N-0371 Oslo, Norway.; Infection Immunology, Norwegian Institute of Public Health, N-0213 Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Sandlie+I%22">Sandlie I</searchLink>; Centre for Immune Regulation (CIR) and Department of Biosciences, University of Oslo, N-0371 Oslo, Norway.; CIR and Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, P.O. Box 4956, N-0424 Oslo, Norway.; Institute of Clinical Medicine and Department of Pharmacology, University of Oslo and Oslo University Hospital, N-0372 Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22James+LC%22">James LC</searchLink>; Protein and Nucleic Acid Chemistry Division, Medical Research Council Laboratory of Molecular Biology, Cambridge CB2-0QH, UK.<br /><searchLink fieldCode="AU" term="%22Andersen+JT%22">Andersen JT</searchLink>; CIR and Department of Immunology, Oslo University Hospital Rikshospitalet and University of Oslo, P.O. Box 4956, N-0424 Oslo, Norway.; Institute of Clinical Medicine and Department of Pharmacology, University of Oslo and Oslo University Hospital, N-0372 Oslo, Norway. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101688624%22">Science immunology</searchLink> [Sci Immunol] 2022 Apr 29; Vol. 7 (70), pp. eabj1640. <i>Date of Electronic Publication: </i>2022 Apr 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+the+Advancement+of+Science%22">American Association for the Advancement of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101688624 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2470-9468 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224709468%22">24709468 </searchLink><i>NLM ISO Abbreviation: </i>Sci Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35486676 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1126/sciimmunol.abj1640 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: eabj1640 Titles: – TitleFull: Potent TRIM21 and complement-dependent intracellular antiviral immunity requires the IgG3 hinge. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Foss S – PersonEntity: Name: NameFull: Jonsson A – PersonEntity: Name: NameFull: Bottermann M – PersonEntity: Name: NameFull: Watkinson R – PersonEntity: Name: NameFull: Lode HE – PersonEntity: Name: NameFull: McAdam MB – PersonEntity: Name: NameFull: Michaelsen TE – PersonEntity: Name: NameFull: Sandlie I – PersonEntity: Name: NameFull: James LC – PersonEntity: Name: NameFull: Andersen JT IsPartOfRelationships: – BibEntity: Dates: – D: 29 M: 04 Text: 2022 Apr 29 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 2470-9468 Numbering: – Type: volume Value: 7 – Type: issue Value: 70 Titles: – TitleFull: Science immunology Type: main |
| ResultId | 1 |
